In many mergers and acquisitions, buyers devote substantial attention to financial due diligence, tax exposures, employment liabilities, and regulatory licences. Yet some of the most significant transaction failures occur for an entirely different reason: the deal cannot obtain competition clearance.
As Thailand's merger control regime continues to mature, antitrust approval has become one of the most critical execution risks in complex acquisitions. A transaction that appears commercially attractive, financially sound, and strategically compelling may nevertheless be delayed for months, subjected to restrictive conditions, or prohibited entirely if it raises concerns regarding market concentration and competitive effects.
For sophisticated buyers, competition law is therefore no longer viewed as a post-signing regulatory formality. It has become a central component of transaction planning, valuation, deal certainty, and risk allocation.
Under Thailand's Trade Competition Act, certain mergers require prior approval from the Trade Competition Commission of Thailand (TCCT) before completion. The requirement generally arises where a transaction may result in a monopoly or create a business operator with a dominant position in the relevant market. One of the key indicators examined by the TCCT is whether the combined business exceeds statutory market share and revenue thresholds established under applicable competition regulations.
The practical significance of these rules cannot be overstated. Unlike many regulatory approvals that can be obtained after completion, pre-merger approval operates as a suspensory condition. Where approval is required, the transaction cannot legally close until the TCCT has completed its review and granted authorisation. Completing a transaction prematurely may expose the parties to significant legal and financial consequences.
As a result, competition clearance frequently becomes one of the most heavily negotiated provisions within the Share Purchase Agreement (SPA). Buyers and sellers must determine who bears the risk of regulatory delay, whether either party is required to accept behavioural or structural remedies imposed by the regulator, and what happens if approval is ultimately denied.
In sophisticated transactions, TCCT approval is commonly treated as a fundamental Condition Precedent to closing. Many SPAs include a "long-stop date" or "drop-dead date" after which either party may terminate the agreement if approval has not been obtained. This approach protects both sides from becoming indefinitely bound to a transaction that may never receive regulatory clearance.
However, the challenge extends far beyond obtaining legal approval. Modern merger control reviews are increasingly driven by economic evidence rather than purely legal arguments. Competition authorities expect parties to demonstrate that the proposed transaction will not substantially harm competition, reduce consumer choice, create barriers to entry, increase prices, diminish innovation, or strengthen market power to an unacceptable degree.
Consequently, financial advisers, economists, accountants, and commercial teams play a critical role in the approval process. The success of a merger filing often depends upon the quality of the market analysis supporting the application.
Parties seeking approval must typically develop detailed assessments of the relevant market, competitive landscape, customer behaviour, market concentration levels, pricing dynamics, barriers to entry, and projected competitive effects following completion. These analyses frequently require sophisticated market-share calculations, revenue modelling, industry forecasts, and economic studies designed to demonstrate that the transaction will not result in anti-competitive outcomes. The submission therefore becomes as much an economic exercise as a legal one.
From a valuation perspective, antitrust risk can materially affect transaction economics. A buyer may agree to pay a premium based upon anticipated synergies, economies of scale, increased market penetration, and enhanced profitability following integration. However, those assumptions may be undermined if the TCCT requires operational restrictions, divestitures, access commitments, pricing limitations, or other remedies as a condition of approval.
In extreme cases, the regulator may conclude that the proposed concentration would substantially lessen competition and therefore refuse approval altogether. Where this occurs, months of negotiation, due diligence expenses, advisory fees, financing arrangements, and management resources may be lost without any transaction being completed.
This reality has significantly changed the way sophisticated acquirers evaluate potential targets. Antitrust due diligence now begins long before transaction documents are signed. Buyers increasingly conduct preliminary competition assessments at the target identification stage, examining market shares, industry concentration levels, competitor positions, customer dependency, and potential regulatory concerns before committing substantial resources to a transaction.
The importance of early analysis is particularly evident in sectors characterised by market concentration, including telecommunications, energy, healthcare, digital platforms, consumer goods, logistics, financial services, and infrastructure-related industries. In these sectors, merger control considerations often become one of the primary drivers of transaction structure and timing.
The accounting implications can also be significant. Acquisition models frequently incorporate expected synergies, revenue enhancements, and cost savings arising from integration. If regulatory conditions prevent the realisation of those assumptions, projected cash flows may require revision, potentially affecting acquisition valuations, goodwill assessments, impairment testing, and future investment returns.
Ultimately, TCCT approval should not be viewed merely as a regulatory filing requirement. It is a transaction-critical risk capable of determining whether a deal closes, when it closes, and whether the expected economic benefits can actually be achieved. The most successful acquirers recognise that competition law is not simply a legal issue it is a strategic, financial, and commercial issue that can influence every stage of an acquisition.
In today's Thai M&A market, the difference between a successful acquisition and a failed transaction often depends not on the purchase price negotiated by the parties, but on whether the parties can convincingly demonstrate that the merger will enhance business efficiency without undermining competition. Where that analysis is overlooked, antitrust approval can quickly become the single greatest obstacle standing between signing and closing.
